Image

The Validity and Reliability of the Turkish Version of the BBAQ

The Validity and Reliability of the Turkish Version of the BBAQ

Recruiting
18-35 years
All
Phase N/A

Powered by AI

Overview

The Barriers to Being Active Quiz (BBAQ) was originally developed in English to identify barriers to physical activity. This study aims to translate and cross-culturally adapt the BBAQ into Turkish (BBAQ-T) and evaluate its psychometric properties.

Description

The study involves the translation and cross-cultural adaptation of the BBAQ into Turkish and the assessment of its reliability and validity. A total of 210 healthy participants will be recruited. The adaptation process will follow a standardized back-translation method using two bilingual translators. A pilot study (n=15) will assess face validity, including linguistic clarity, conceptual relevance, and administration time. To evaluate test-retest reliability, participants will complete the BBAQ-T again within 5-7 days after the initial assessment. Internal consistency will be analyzed using Cronbach's alpha (α). Construct validity will be examined by correlating the BBAQ-T with the Turkish versions of the Self-Perceived Barriers for Physical Activity Questionnaire and the Short Form-12 (SF-12).

Eligibility

Inclusion Criteria:

  • Aged 18 years or older
  • Ability to read and write in Turkish
  • No visual or hearing impairments that would interfere with participation
  • Ability to follow simple instructions
  • Willingness to participate in the study

Exclusion Criteria:

  • Diagnosis of rheumatological conditions that may limit physical activity and are characterized by chronic inflammation and/or joint deformities (e.g., rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus, psoriatic arthritis)
  • Physical limitations due to neurological or orthopedic conditions (e.g., stroke, cerebral palsy, multiple sclerosis, limb amputation, or orthopedic surgery within the past six months)
  • History of psychiatric disorders that may impair cognitive functioning (e.g., schizophrenia, bipolar disorder, severe depression, attention deficit hyperactivity disorder)
  • Presence of any cognitive impairment

Study details
    Health Knowledge
    Attitudes
    Practice
    Physical Inactivity

NCT06978686

Istanbul Medeniyet University

21 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.